Janus Kinase Inhibition in the Aicardi–Goutières Syndrome

Adeline Vanderver; Laura Adang; Francesco Gavazzi; Katherine McDonald; Guy Helman; David B. Frank; Nicole Jaffe; Sabrina W. Yum; Abigail Collins; Stephanie R. Keller; Pierre Lebon; Jean-François Meritet; Jullie Rhee; Asako Takanohashi; Thais Armangue; Nicole Ulrick; Omar Sherbini; Jamie Koh; Kyle Peer; Constance Besnier; Carly Scher; Katherine Boyle; Holly Dubbs; Julia Kramer-Golinkoff; Amy Pizzino; Sarah Woidill; Justine Shults

Journal ArticleOPEN ACCESS

Janus Kinase Inhibition in the Aicardi–Goutières Syndrome

Vanderver A
Adang L
Gavazzi F
et al.

New England Journal of Medicine (2020) 383(10) 986-989

DOI: 10.1056/nejmc2001362

122Citations

149Readers

Abstract

JAK Inhibition in the Aicardi–Goutières Syndrome Patients with the Aicardi–Goutières syndrome, an autosomal recessive disorder that affects the central nervous system, immune system, and skin, have...

Cite

CITATION STYLE

APA

Vanderver, A., Adang, L., Gavazzi, F., McDonald, K., Helman, G., Frank, D. B., … Shults, J. (2020). Janus Kinase Inhibition in the Aicardi–Goutières Syndrome. New England Journal of Medicine, 383(10), 986–989. https://doi.org/10.1056/nejmc2001362

Janus Kinase Inhibition in the Aicardi–Goutières Syndrome

Abstract

Cite

Register to see more suggestions